Home|Journals|Articles by Year Follow on Twitter

Directory for Medical Articles

Open Access

Original Article

J App Pharm Sci. 2015; 5(4): 053-057

Effect of Plumbago zeylanica administration on brain neurotransmitter level in Wistar albino rats

Muthukumarasamy Baskaran, Latha Shanmugam, Vijayakumar Raman.

According to WHO about 80% of the world’s population relies on traditional medicine for their primary health care.Plumbago zeylanica L. is a medicinal plant, belong to the family of Plumbaginaceae and the root of P. zeylanica contains several bioactive constituent like L-dopa, Plumbagin (naphthoquinone), droseron, chitranone, triterpenoid, anthraquinone. This study is designed to evaluate the effect of P. zeylanica and naphthoquinone on the level of various amine neurotransmitters namely epinephrine, norepinephrine, serotonin, 5-hydroxyindole 3-acetic acid (5-HIAA), and dopamine on the discrete regions of the brain tissues. Wistar male albino rats were treated separately with ethanoloic extract of P.zeylannica (root) and the commercially purchased phytochemical naphthoquinone at the dose of 2mg/kg b.wt with different experimental groups. The brain tissue homogenates (cerebral cortex, cerebellum, hypothalamus, pons-medulla, midbrain, and corpus striatum) were analyzed to quantify the aforementioned neurotransmitters by high performance liquid chromatography (HPLC). The results showed that, administration of P. zeylanicaand NQ does not alter the many of the studied neurotransmitter at significant level; however, there is a change in the neurotransmitter profile in few specific regions of Wistar rat brain and striatum was found to be affected more.

Key words: Plumbago zeylanica, Naphthoquinone, Plumbagin, Brain neurotransmitter, HPLC

Similar Articles

Emerging roles of NRBF2/PI3KC3 axis in maintaining homeostasis of brain and guts.
Wu MY, Cai CZ, Yang C, Yue Z, Chen Y, Bian ZX, Li M, Lu JH
Neural regeneration research. 2022; 17(2): 323-324

Boosting proteolytic pathways as a treatment against glycation-derived damage in the brain?
Taylor A, Bejarano E
Neural regeneration research. 2022; 17(2): 320-322

Delving into the recent advancements of spinal cord injury treatment: a review of recent progress.
Flack JA, Sharma KD, Xie JY
Neural regeneration research. 2022; 17(2): 283-291

Neat1 decreases neuronal apoptosis after oxygen and glucose deprivation.
Chai WN, Wu YF, Wu ZM, Xie YF, Shi QH, Dan W, Zhan Y, Zhong JJ, Tang W, Sun XC, Jiang L
Neural regeneration research. 2022; 17(1): 163-169

Cell cycle exit and neuronal differentiation 1-engineered embryonic neural stem cells enhance neuronal differentiation and neurobehavioral recovery after experimental traumatic brain injury.
Wang R, Yang DX, Liu YL, Ding J, Guo Y, Ding WH, Tian HL, Yuan F
Neural regeneration research. 2022; 17(1): 130-136

Full-text options

Add your Article(s) to Indexes
• citeindex.org

Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright © ScopeMed® Information Services.